BSX Related Company Press Releases
-
Boston Scientific Vercise™ DBS System demonstrates Improvement In Motor Function For Patients With Parkinson's Disease
-
Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise™ DBS System In Treatment Of Parkinson's Disease
-
Boston Scientific Announces Collaboration with Pelvic Floor Disorders Network to Study Treatment Strategies for Uterine Prolapse
-
The World Stroke Organization and Boston Scientific Join Forces to Bolster Awareness and Advocacy Efforts
-
Boston Scientific Receives CE Mark Approval For GUIDE™ DBS System
-
Boston Scientific To Participate In The 38th Annual Deutsche Bank 2013 Healthcare Conference
-
Belo Sun Reports Positive Results From Preliminary Metallurgical Leach Test Work Conducted With Volta Grande South Block Samples With Average Recoveries of 95% and Reports AGM Results
-
New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
-
Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial
-
Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data
-
Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out to Five Years in Patients with Severe Asthma
-
OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings
-
Boston Scientific Presents Clinical Data at Digestive Disease Week®
-
Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
-
Vascular Solutions Files Patent Infringement Complaint Against Boston Scientific
-
First Patient Enrolled In Boston Scientific Randomized Study Comparing WallFlex® Biliary RX Stent To Absence Of Biliary Drainage In Patients With Pancreatic Or Periampullary Cancers
-
OrbusNeich obtains additional preliminary injunction against Boston Scientific in Germany
-
Data From More Than 100,000 Boston Scientific Implantable Defibrillators Show Battery Longevity Projections Of Nine To 13 Years
-
Boston Scientific Receives CE Mark Approval For The Rhythmia™ Mapping System
-
New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The
-
Boston Scientific To Participate In The Bank Of America Merrill Lynch 2013 Healthcare Conference
-
There's More To Asthma Than Meets The Air
-
Belo Sun Mining Completes Pre-Feasibility Study
-
Boston Scientific Completes First-In-Human Clinical Trial of the IntellaTip MiFi™ XP Ablation Catheter For Patients With Type 1 Atrial Flutter
-
Boston Scientific Schedule of Major Events and Presentations at Heart Rhythm 2013
-
OrbusNeich obtains preliminary injunction in patent infringement proceedings in Germany against Boston Scientific
-
Boston Scientific Announces Results For First Quarter Ended March 31, 2013
Back to BSX Stock Lookup
